financetom
Business
financetom
/
Business
/
Kimberly-Clark to reorganize business, incur $1.5 billion in costs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kimberly-Clark to reorganize business, incur $1.5 billion in costs
Mar 27, 2024 5:41 AM

(Reuters) - Kimberly-Clark ( KMB ) said on Wednesday it would reorganize into three business units as the Kleenex tissue maker looks to simplify operations and cut costs.

The Irving, Texas-based consumer goods maker said it would incur about $1.5 billion in related costs over the next three years.

Cash costs are expected to be about half of that amount, primarily related to workforce reductions, it said in a filing without disclosing the number of jobs it would cut.

The restructuring comes at a time when the company is seeing benefits from its consistent price hikes wane and inflation-stricken customers pull back on purchasing its pricier products.

Kimberly-Clark ( KMB ), like its peers Procter & Gamble and Unilever, is also losing shelf-space at retailers to more affordable private-label alternatives.

The company's reorganized segments will now include its business in North America, the international personal care segment and the international family care and professional businesses.

It previously had three business segments - personal care, consumer tissue and Kimberly-Clark ( KMB ) professional - with each having three geographic sub-divisions.

The company said its planned supply chain modernization is expected to generate more than $3 billion in gross productivity and $500 million in working capital savings that would be used for growth investments.

Kimberly-Clark ( KMB ) expects to complete its transition to the new organizational structure by the end of 2024. The actions are expected to generate about $200 million of selling, general and administrative savings in the next few years.

The company also reaffirmed its annual organic net sales and adjusted profit targets it had provided in January.

It had missed fourth-quarter sales and profit estimates in January and warned that weak retail inventories could lead to flat volumes in the first quarter.

Kimberly-Clark's ( KMB ) shares were up 1.5% before the bell.

(Reporting by Granth Vanaik in Bengaluru; Editing by Shilpi Majumdar and Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
First Phosphate Closes Private Placement to Strategic Investor
First Phosphate Closes Private Placement to Strategic Investor
Jul 9, 2025
11:14 AM EDT, 07/09/2025 (MT Newswires) -- First Phosphate ( FRSPF ) on Wednesday said raised $3.23 million as it closed a financing to the strategic investor and other follow-on investors. The company said it issued 9.1 million flow-through shares at a price of $0.35 each for gross proceeds of $3.2 million. It also sold 100,142 hard dollar units priced...
Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On?
Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On?
Jul 9, 2025
Shares of Evoke Pharma Inc ( EVOK ) are trading sharply higher Wednesday morning after the specialty pharmaceutical company announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a new patent covering its lead product, GIMOTI. What To Know: The nasal spray is a treatment for adults with moderate to severe symptoms of...
Linda Yaccarino, CEO of Elon Musk's X, to step down in surprise move
Linda Yaccarino, CEO of Elon Musk's X, to step down in surprise move
Jul 9, 2025
July 9 (Reuters) - Elon Musk-owned social platform X's CEO Linda Yaccarino said on Wednesday she would step down from the role in a surprise move. Her exit comes at a difficult time for Musk, who is dealing with falling sales at his EV maker Tesla and is embroiled in a war of words with U.S. President Donald Trump. Yaccarino...
Copyright 2023-2026 - www.financetom.com All Rights Reserved